SCHEMBL8944350

SCHEMBL8944350

COc1ccc(N(c2ccccc2)c2ccc(-c3ccccc3)cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.50
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
ALDH1A1 P00352 2/20 0.50
LMNA P02545 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
CA4 P22748 1/20 0.50
BACE1 P56817 2/20 0.49
ABL1 P00519 1/20 0.48
ABCB1 P08183 1/20 0.48
BCR P11274 1/20 0.48
LTA4H P09960 1/20 0.48
ESR2 Q92731 1/20 0.47
MITF O75030 1/20 0.46
HTT P42858 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
ENPP3 O14638 1/20 0.46
ENPP1 P22413 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10160618 1.00 KDM4E (0.50) KDM4ENPC1RAB9AALDH1A1LMNA
SCHEMBL13879190 1.00 KDM4E (0.50) KDM4ENPC1RAB9AALDH1A1LMNA
SCHEMBL131837 0.98 CA4 (0.52) KDM4ENPC1RAB9AALDH1A1LMNA
SCHEMBL15807457 0.98 CA4 (0.52) KDM4ENPC1RAB9AALDH1A1LMNA
SCHEMBL10057794 0.98 CA4 (0.52) KDM4ENPC1RAB9AALDH1A1LMNA
SCHEMBL10057799 0.98 CA4 (0.52) KDM4ENPC1RAB9AALDH1A1LMNA
SCHEMBL16508421 0.98 CA4 (0.52) KDM4ENPC1RAB9AALDH1A1LMNA
SCHEMBL6139896 0.98 CA4 (0.52) KDM4ENPC1RAB9AALDH1A1LMNA
SCHEMBL13715237 0.98 CA4 (0.52) KDM4ENPC1RAB9AALDH1A1LMNA
SCHEMBL12677664 0.98 CA4 (0.52) KDM4ENPC1RAB9AALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2278407-B1 Image forming apparatus RICOH CO LTD (JP) 2012-10-10 EP disclosed
US-20090118521-A1 NANOENGINEERED ORGANIC NONLINEAR OPTICAL GLASSES WASHINGTON, UNIVERSITY OF (US) 2009-05-07 US disclosed
US-5480765-A PRESSURE AND HEAT SENSITIVE PAPER, IMPROVED PHOTOSTABILITY BY ADDITION OF TRIARYLAMINE COMPOUND FUJI PHOTO FILM CO., LTD. (JP) 1996-01-02 US disclosed
US-5227449-A Polydiphenylsiloxane-Carbonate Block Polymers XEROX CORPORATION (US) 1993-07-13 US disclosed
US-5215844-A Photoconductive imaging members with polyhydroxy ether binders XEROX CORPORATION (US) 1993-06-01 US disclosed
US-5166021-A Multilayer imaging member with charge generating and charge transport layers XEROX CORPORATION (US) 1992-11-24 US disclosed
US-5162485-A Binders in charge transport or charge generation layers XEROX CORPORATION (US) 1992-11-10 US disclosed
US-5080987-A Photoconductive imaging members with polycarbonate binders XEROX CORPORATION (US) 1992-01-14 US disclosed
US-5011906-A Photoconductive imaging members with N,N-bis(biarylyl)aniline charge transport polymers XEROX CORPORATION (US) 1991-04-30 US disclosed
US-5008169-A Photoconductive imaging members with polyphosphazenes XEROX CORPORATION (US) 1991-04-16 US disclosed
US-5004663-A Photoconductive imaging members with polyphosphazene binders XEROX CORPORATION (US) 1991-04-02 US disclosed
US-4959288-A Photoconductive imaging members with diaryl biarylylamine copolymer charge transport layers XEROX CORPORATION (US) 1990-09-25 US disclosed
US-4946754-A Photoconductive imaging members with diaryl biarylylamine charge transporting components XEROX CORPORATION (US) 1990-08-07 US disclosed
US-4937165-A Photoconductive imaging members with N,N-bis(biarylyl)aniline charge transport polymers XEROX CORPORATION (US) 1990-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118521-A1 NANOENGINEERED ORGANIC NONLINEAR OPTICAL GLASSES EYA3, CDH1, EYA2 KDM4E 1607/4885NPC1 1271/4885RAB9A 930/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.